Treatment of Staphylococcus Urinary Tract Infection
For uncomplicated Staphylococcus saprophyticus cystitis in women, treat with nitrofurantoin 100 mg twice daily for 5 days as first-line therapy, or alternatively use fosfomycin 3g single dose or pivmecillinam 400 mg three times daily for 3-5 days 1.
Key Treatment Principles
The 2024 European Association of Urology guidelines provide clear direction for uncomplicated UTIs, though they focus primarily on E. coli as the predominant pathogen. However, Staphylococcus saprophyticus is explicitly recognized as a common uropathogen in uncomplicated UTIs, particularly in young, sexually active women 2, 3.
First-Line Antibiotic Selection
For women with uncomplicated cystitis caused by Staphylococcus:
- Nitrofurantoin: 100 mg twice daily for 5 days (macrocrystals or monohydrate formulations) 1
- Fosfomycin trometamol: 3g single dose 1
- Pivmecillinam: 400 mg three times daily for 3-5 days (recently FDA-approved with demonstrated efficacy against S. saprophyticus) 4
These agents are preferred because they:
- Achieve high urinary concentrations
- Have minimal "collateral damage" (don't promote multidrug-resistant organisms)
- Maintain excellent activity against common uropathogens including Staphylococcus species
Alternative Agents
If first-line options are unavailable or contraindicated:
- Cephalosporins (e.g., cefadroxil 500 mg twice daily for 3 days) - only if local E. coli resistance <20% 1
- Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 3 days in women, or 7 days in men 1
Important caveat: Fluoroquinolones should be avoided for simple cystitis due to ecological concerns and the need to preserve these agents for more serious infections 1, 5.
Treatment Duration by Clinical Syndrome
Uncomplicated Cystitis
Men with UTI
All UTIs in men are considered complicated by definition. Treat for 7 days minimum with TMP-SMX 160/800 mg twice daily, or use fluoroquinolones based on local susceptibility 1.
Pyelonephritis
If Staphylococcus causes pyelonephritis (uncommon but possible):
- Oral outpatient: Fluoroquinolones (ciprofloxacin 500-750 mg twice daily for 7 days or levofloxacin 750 mg daily for 5 days) 1
- Intravenous: Ceftriaxone 1-2g daily, cefepime 1-2g twice daily, or fluoroquinolones 1
Critical Diagnostic Considerations
Obtain urine culture before treatment in these situations 1:
- Suspected pyelonephritis
- Symptoms not resolving or recurring within 4 weeks
- Atypical symptoms
- Pregnancy
- Male patients
- Complicated UTI risk factors
Do not routinely culture asymptomatic patients post-treatment 1.
Special Populations
Catheter-Associated UTI
Major pitfall: Staphylococcus aureus (including MRSA) is an emerging CAUTI pathogen that binds to fibrinogen deposited on catheters 6. For symptomatic CAUTI:
- Remove or replace catheter if possible
- Obtain culture before treatment
- Use culture-directed therapy based on susceptibilities
- Consider broader coverage initially if systemically ill
Pregnancy
Asymptomatic bacteriuria with Staphylococcus must be treated in pregnancy (unlike non-pregnant patients) 1. Use:
- Nitrofurantoin (avoid near term)
- Cephalosporins
- Fosfomycin
Avoid: Trimethoprim in first trimester, TMP-SMX in last trimester 1.
When Treatment Fails
If symptoms persist or recur within 2 weeks 1:
- Obtain urine culture with susceptibilities
- Assume resistance to initial agent
- Retreat with different antibiotic class for 7 days
- Consider complicated UTI if pattern continues
Common Pitfalls to Avoid
- Don't use fluoroquinolones for simple cystitis - reserve for pyelonephritis or complicated infections
- Don't treat asymptomatic bacteriuria (except pregnancy or pre-urologic procedures) 1, 5
- Don't assume all Staphylococcus in urine is S. saprophyticus - S. aureus suggests complicated infection or CAUTI
- Don't use nitrofurantoin, fosfomycin, or pivmecillinam for pyelonephritis - insufficient tissue penetration 1